Purchase Order 36C24424P0225

Award Date 1/27/24
Potential Completion Date 1/26/25
Potential Value $92K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Philadelphia, PA 19104, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Service Contract Inventory
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Department of Veterans Affairs (VA) Veterans Health Administration awarded a $113,291.46 firm-fixed-price purchase order contract to Nuclear Diagnostic Products, Inc., a for-profit organization, to provide the radiopharmaceutical NETSPOT (GA-68 DOTATATE). This contract supports nuclear medicine services at multiple VA medical centers in New York, New Jersey, and Delaware, and has a period of performance through January 8, 2024. The contract was awarded on January 9, 2023 and was not set...
The Department of Veterans Affairs (VA) has awarded a firm fixed price purchase order contract to Nuclear Diagnostic Products, Inc., a for-profit organization, to provide GA-68 NETSPOT radiopharmaceuticals. The $42,000.00 contract has a completion date of January 26, 2024. This award is under the Total Small Business set-aside program and will supply the VA's Veterans Integrated Service Network 4, which covers facilities in Pennsylvania. Nuclear Diagnostic Products, Inc. is an experienced...
This is a firm fixed-price purchase order awarded by the U.S. Department of Veterans Affairs (VA) to Nuclear Diagnostic Products, Inc., a for-profit organization specializing in the supply of radiopharmaceuticals. The contract, valued at $34,371.90, is for the delivery of BRIDGE NETSPOT GA68, a radiopharmaceutical product used in nuclear medicine imaging procedures. The contract is not set aside for any specific business type. Nuclear Diagnostic Products, Inc. has been awarded numerous prime...
This federal contract award was issued by the U.S. Department of Veterans Affairs (VA) to Nuclear Diagnostic Products, Inc., a for-profit company specializing in the supply of radiopharmaceuticals for the VA healthcare system. The $111,392.95 delivery order is part of a larger Indefinite Delivery Contract (IDC) worth $4,038,178.15 with the VA's Veterans Integrated Service Network (VISN) 2 for general radiopharmaceuticals, with a performance period through February 2026. The contract does not...
The Department of Veterans Affairs (VA) has awarded a firm fixed price delivery order contract to Nuclear Diagnostic Products, Inc., a for-profit organization, to provide general radiopharmaceuticals for the VA's Veterans Integrated Service Network (VISN) 2, which covers facilities in New York and New Jersey. This $610,950.85 contract has a completion date of February 21, 2024. Nuclear Diagnostic Products, Inc. is the prime contractor and has been awarded numerous similar contracts by the VA...
This federal contract award is for the supply of radiopharmaceuticals to the U.S. Department of Veterans Affairs (VA) healthcare system. The prime contractor, Nuclear Diagnostic Products, Inc., is a for-profit organization that specializes in providing these critical medical imaging compounds. The contract, valued at $363,610.10, is a delivery order contract with a firm fixed price pricing type. It does not have a set-aside designation. Nuclear Diagnostic Products, Inc. has been awarded...
This federal contract award, valued at $103,865.20, was issued by the U.S. Department of Veterans Affairs (VA) to Nuclear Diagnostic Products, Inc. for the provision of general radiopharmaceuticals to support the Veterans Integrated Service Network (VISN) 2 healthcare system. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) held by the company, which provides specialized radiopharmaceutical products to VA medical centers in the northeastern United States....
Nuclear Diagnostic Products, Inc. was awarded a firm fixed price delivery order for $995,667.70 by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 2 (VISN 2) to provide general radiopharmaceuticals. The contract has no set-aside designation. Performance will take place in Rockaway, New Jersey and work is required to be completed by February 21, 2025. Nuclear Diagnostic Products is the prime contractor and will supply radiopharmaceuticals from...
This is a $80,500.00 firm fixed-price purchase order awarded by the Department of Veterans Affairs' Veterans Integrated Service Network 22 to Advanced Accelerator Applications USA Inc., a foreign-owned, for-profit manufacturer of radiopharmaceuticals and nuclear medicine products. The contract is for the delivery of NETSPOT, a radiopharmaceutical product used in nuclear medicine diagnostic imaging procedures. The contract is not set aside for small businesses. Advanced Accelerator Applications...
The Department of Veterans Affairs Veterans Health Administration awarded a $345,800 firm fixed price purchase order to Advanced Accelerator Applications USA Inc. to supply 68GA DOTATATE, also known as NETSPOT Gallium Ga 68 Dotatate, a radioactive diagnostic agent used in nuclear imaging services. The five-year contract runs from October 2020 through September 2025 and will support imaging needs at the VA facility in Las Vegas, Nevada on an as-needed basis. The sole source award was made as...

The U.S. Department of Veterans Affairs (VA) awarded a firm fixed-price purchase order contract to Nuclear Diagnostic Products, Inc., a for-profit organization headquartered in Rockaway, New Jersey. The contract, valued at $91,658.40, is for the supply of GA-68 NETSPOT, a radiopharmaceutical product used in nuclear medicine diagnostic procedures, to support the VA's healthcare services for veterans. This contract is not a set-aside award. Nuclear Diagnostic Products, Inc. is an established supplier of radiopharmaceuticals to the VA, holding several Indefinite Delivery Contracts (IDCs) with the agency's Veterans Health Administration, including a $4,038,178.15 IDC for general radiopharmaceuticals and a $4,987,500 IDC for the ILLUCCIX product. The contract is intended to support VA medical imaging programs within the agency's Veterans Integrated Service Network 4 (VISN 4), which covers the northeastern United States.

Generated 5/16/25, 12:27 PM